Watchlist Price Alert

Arbutus Biopharma Corpora... (ABUS)

NASDAQ: ABUS · Real-Time Price · USD

3.33

-0.18 (-5.13%)

At close: May 06, 2025, 3:59 PM

3.37

1.05%

After-hours: May 06, 2025, 06:06 PM EDT

Arbutus Biopharma Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Net Income	-69.92M	-72.85M	-69.46M	-76.25M	-63.74M	-153.72M	-57.1M	-84.4M	-384.16M
Depreciation & Amortization	1.38M	1.4M	1.43M	1.75M	1.98M	2.03M	2.18M	2.03M	1.09M
Stock-Based Compensation	8.99M	9.3M	7.18M	6.42M	6.16M	6.8M	6.24M	15.12M	39.16M
Other Working Capital	511K	-18.23M	24.48M	517K	-1.13M	-42K	-2.74M	3.42M	-1.07M
Other Non-Cash Items	-2.47M	-5.56M	-3.75M	7.79M	9.33M	88.78M	-10.66M	39.83M	391.56M
Deferred Income Tax	n/a	n/a	n/a	-8.18M	-5.59M	-12.66M	-4.28M	-24.32M	-105.06M
Change in Working Capital	-2.83M	-18.23M	29.24M	930K	431K	-2.23M	-4.28M	3.15M	-467K
Operating Cash Flow	-64.85M	-85.94M	-35.36M	-67.53M	-51.44M	-71.01M	-67.9M	-48.6M	-57.88M
Capital Expenditures	-182K	-1.01M	-512K	-809K	-229K	-589K	-1.14M	-7.26M	-4M
Cash Acquisitions	n/a	n/a	458K	1.81M	-2.5M	11K	25K	3K	25K
Purchase of Investments	-141.51M	-80.51M	-130.43M	-82.22M	-85.58M	-58.76M	-3.01M	n/a	-95.15M
Sales Maturities Of Investments	n/a	132.27M	56M	70.35M	73.4M	87.67M	n/a	35.09M	n/a
Other Investing Acitivies	164.64M	20K	-458K	-1.81M	-12.18M	28.93M	-2.96M	35.06M	25K
Investing Cash Flow	22.95M	50.77M	-74.94M	-12.68M	-14.91M	28.34M	-4.1M	27.8M	-99.12M
Debt Repayment	n/a	n/a	n/a	n/a	n/a	n/a	-12M	n/a	12M
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	-12.14M	-12.12M	-11.15M	-10.09M	n/a	n/a
Other Financial Acitivies	7.87M	795K	11.49M	14.71M	12.57M	30M	11.47M	453K	637K
Financial Cash Flow	52M	30.65M	31.81M	137.24M	86.75M	37.46M	55.6M	49.3M	12.64M
Net Cash Flow	10.04M	-4.49M	-78.51M	57.03M	20.45M	-5.14M	-17.4M	30.9M	-143.37M
Free Cash Flow	-65.03M	-86.94M	-35.87M	-68.34M	-51.67M	-71.59M	-69.04M	-55.86M	-61.88M